Gyrone-NCR Tablet contains Norethisterone 10 mg, a synthetic progestogen used primarily in the management of menstrual disorders and gynecological conditions. Norethisterone acts by mimicking the natural hormone progesterone, thereby regulating the menstrual cycle and stabilizing the endometrium. It is indicated for the treatment of menstrual irregularities such as menorrhagia, metrorrhagia, and secondary amenorrhea, as well as for delaying menstruation when clinically necessary. Additionally, Gyrone-NCR is utilized in the management of endometriosis and as part of hormone replacement therapy. The tablet is administered orally, with dosage tailored according to the specific condition and patient response. Common side effects may include nausea, headache, breast tenderness, and mood changes, though these are generally mild and transient. Contraindications include known hypersensitivity to norethisterone or other progestogens, active thromboembolic disorders, liver disease, and hormone-sensitive malignancies. Caution is advised in patients with cardiovascular risk factors and a thorough medical evaluation should precede therapy initiation. Gyrone-NCR Tablet should be used under medical supervision to ensure optimal therapeutic outcomes and minimize adverse effects.